During the past decade, Przychodnia Specjalistyczna PROSEN conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Przychodnia Specjalistyczna PROSEN" #1 collaborator was "Sucampo AG" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Przychodnia Specjalistyczna PROSEN" are "Dyslipidemia" (4 trials), "Alzheimer's Disease" (2 trials), "Constipation - Functional" (2 trials), "Type II Diabetes Mellitus" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Przychodnia Specjalistyczna PROSEN" in a lesser frequency.

Most popular intervention types in "Przychodnia Specjalistyczna PROSEN" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (4 trials), "Atorvastatin" (3 trials), "Placebo" (3 trials), "Gantenerumab" (2 trials) and "Lubiprostone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Przychodnia Specjalistyczna PROSEN" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Przychodnia Specjalistyczna PROSEN". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Przychodnia Specjalistyczna PROSEN, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Przychodnia Specjalistyczna PROSEN, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".